Newswise — University of the Sciences in Philadelphia (USP), on behalf of its Advanced Concepts Institute (ACI), announced a relationship with Sanovia Corporation today. The first initiative to be undertaken by ACI and Sanovia will be to develop a library of evidence-based guidelines for the appropriate use of high-cost pharmaceuticals and biotech products.

To accomplish the goal of developing an independent library of evidence-based prior authorization (PA) criteria, a Clinical Excellence Council (CEC) will be formed to review and approve the guidelines and criteria based upon current research. The CEC will be composed of independent healthcare practitioners and leading experts, including pharmacists and physicians from academia and managed care organizations. Ultimately, Sanovia will use the approved library of guidelines and criteria for the benefit of its clients to improve patient health outcomes while also potentially lowering costs.

"This is a terrific opportunity to utilize the vast expertise of faculty and staff at University of the Sciences in Philadelphia and other organizations to develop an independently reviewed set of criteria, grounded on practice and evidence in the literature," said Shawn P. Curtin, Executive Director of ACI and Assistant Dean, Finance and Entrepreneurial Affairs for Philadelphia College of Pharmacy. "We look forward to building a strong and lasting relationship with Sanovia."

"We are very pleased that USP's Advanced Concepts Institute has agreed to partner with us on this important project," said Robert E. Tremain, President and CEO of Sanovia. "With a truly independent Clinical Excellence Council, we can ensure our clients that these guidelines for managing high cost pharmaceutical products are truly focused on appropriateness and quality for the patient. As our nation's first College of Pharmacy, USP continues to lead the way on innovation."

About Sanovia, 300 Stevens Drive "¢ Suite 330 "¢ Philadelphia, PA 19113: A national company based in Philadelphia, Pennsylvania, Sanovia integrates smart business practices with automated decision-making technology and evidence-based clinical guidelines delivering proven savings in pharmaceutical spending for managed care companies and their customers. Sanovia's portfolio of innovative products and services meet the increasing challenges of Pharmaceutical Administration, Validation, Documentation, Utilization, Cost and Workflow Management. Clients use Sanovia's "intelligent" clinical decision support products to balance pharmaceutical cost management with appropriateness of therapy and quality of care. Sanovia is privately held with no ownership held by any Pharmacy Benefit Manager (PBM), health plan or pharmaceutical manufacturer.

About USP, 600 South 43rd St. "¢ Philadelphia, PA 19104: University of the Sciences in Philadelphia is a private, coeducational institution founded in 1821 as Philadelphia College of Pharmacy, the nation's first college of pharmacy. It is where the founders of six of the top pharmaceutical companies in the world launched their futures. Comprising four colleges across a broad range of majors, USP specializes in educating its 2,800 students for rewarding careers through its undergraduate, graduate, and doctoral degree programs in pharmacy, science, and the health sciences. ACI is a department of the University founded to build and grow USP's partnerships with healthcare organizations. ACI provides customized solutions through various services including health outcomes research, interventional demonstration projects, formulary support, customized professional education and training, and publication initiatives.